Molecular imaging is an area of medical imaging that focuses on imaging molecules of medical concern in living patients. It is integrated advanced imaging technology with molecular and cellular biology. It is safe, noninvasive, and painless procedure that is used to diagnose and manage a wide range of diseases such as cardiovascular, neurology, oncology, respiratory, and gastrointestinal. Molecular imaging is field of nuclear medicine. It includes small amount of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Moreover, molecular imaging helps to physician to disease management and improve personalize patient care.
Market Dynamics
Molecular imaging has become a part of the standard care for various types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has significantly impacted the clinical management of cancer. Thus, increasing awareness of the early diagnosis is likely to boost the demand for diagnostic products such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), positron emission tomography-computed tomography (PET-CT), single-photon emission computed tomography-computed tomography (SPECT-CT), etc. This, in turn, is expected to drive the global molecular imaging market growth. Moreover, a surge in the adoption of technologically advanced products is expected to drive the market growth. For instance, in June 2021, a leading provider of diagnostic imaging systems Canon Medical Systems USA Inc. a leading provider of diagnostic imaging systems, deep Learning Reconstruction (DLR) technology and Advanced intelligent Clear-IQ Engine (AiCE), both used in Cartesion Prime Digital PET/CT system, received 510(k) clearance from the U.S. Food and Drugs Administration (FDA). The Cartesion Prime with AiCE help clinicians consistently and routinely produce high-quality images.
Key features of the study:
- This report provides an in-depth analysis of the global molecular imaging market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global molecular imaging market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies.
- Key companies covered as a part of this study include GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, UNITED IMAGING HEALTHCARE CO., LTD., Mediso kft., Positron Corporation, ESAOTE S.P.A., Carestream Health, Mirada Medical Limited, and Hermes Medical Solutions
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global molecular imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular imaging market.
Detailed Segmentation:
- Global Molecular Imaging Market, By Product Type :
-
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography- Computed Tomography (PET-CT)
- Positron Emission Tomography- Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- Global Molecular Imaging Market, By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- Global Molecular Imaging Market, By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Global Molecular Imaging Market, By Region:
- North America
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- Latin America
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type
- Devices
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
- Positron Emission Tomography - Computed Tomography (PET-CT)
- Positron Emission Tomography - Magnetic Resonance (PET-MR)
- Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
- Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
- Software Platforms
- On Premises Solutions
- Cloud Based Solutions
- By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
- Other Applications
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- GE Healthcare*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bruker Corporation
- Fujifilm Holdings Corp.
- Siemens Healthineers
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
- Mediso kft.
- Positron Corporation
- ESAOTE S.P.A.
- Carestream Health
- Mirada Medical Limited
- Hermes Medical Solutions
“*” marked represents similar segmentation in other categories in the respective section.
